Indian Pharmacopoeia Commission (IPC) signs three MoUs to strengthen drug safety

Key facts

• The Indian Pharmacopoeia Commission (IPC), an autonomous body under the Ministry of Health and Family Welfare, signed memoranda of understanding (MoU) with the Goa State Pharmacy Council (GSPC), Quality Council of India (QCI), and HLL Infra Tech Services Limited.
• The agreements aim to strengthen pharmacovigilance systems, enhance professional competencies, and promote uniform standards for medicine quality and patient safety across India.
• The MoU with the GSPC focuses on the professional development of pharmacists, promotion of the National Formulary of India, and strengthening adverse drug reaction (ADR) reporting mechanisms.
• The collaboration with the GSPC supports the establishment of ADR Monitoring Centres and enhances systematic reporting and documentation practices across healthcare facilities.
• The IPC and the QCI will collaborate on quality promotion, public health awareness, and capacity building through joint training and awareness programmes in pharmacovigilance.
• Harsh Mangla, Joint Secretary in the Ministry of Health and Family Welfare, emphasised that the MoUs must translate into the achievement of objectives to improve primary and secondary healthcare.